VANGUARD GROUP INC - MONOPAR THERAPEUTICS INC ownership

MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 14 filers reported holding MONOPAR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of MONOPAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$54,301
-36.0%
87,596
-11.7%
0.00%
Q2 2023$84,796
-39.0%
99,176
-0.8%
0.00%
Q1 2023$138,977
-41.3%
99,9760.0%0.00%
Q4 2022$236,943
+55.9%
99,976
+0.1%
0.00%
Q3 2022$152,000
-33.9%
99,8790.0%0.00%
Q2 2022$230,000
-9.8%
99,8790.0%0.00%
Q1 2022$255,000
-20.6%
99,8790.0%0.00%
Q4 2021$321,000
-34.1%
99,8790.0%0.00%
Q3 2021$487,000
-15.2%
99,879
+2.5%
0.00%
Q2 2021$574,000
+105.7%
97,462
+116.2%
0.00%
Q1 2021$279,00045,0700.00%
Other shareholders
MONOPAR THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
American Portfolios Advisors 700$1,6100.00%
ROYAL BANK OF CANADA 4,116$9,0000.00%
VANGUARD GROUP INC 99,879$230,0000.00%
UBS Group AG 19,561$45,0000.00%
IFP Advisors, Inc 500$13,0000.00%
FMR LLC 10$00.00%
WELLS FARGO & COMPANY/MN 29$00.00%
NORTHERN TRUST CORP 35,203$81,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 39,171$85,0000.00%
View complete list of MONOPAR THERAPEUTICS INC shareholders